Research
The primary goal of our research is to develop novel microfluidics, electrochemistry, and nanomaterials based effective molecular diagnostics technologies and point-of-care devices for early detection and management of cancer and maternal health diseases. We are working together with chemists, biomedical engineers, biologists and clinicians for achieving this goal. We also work on the development of simple and inexpensive technologies, such as sensors and ‘on-farm’ devices for the detection and management of plant and crops diseases.
Research Theme

Our research activity focuses on the development of advanced molecular diagnostics technologies and point-of-care devices for early detection and management of diseases. Our highly multidisciplinary research activities combine the fundamental and translational studies at the interface between chemistry, physics, nanotechnology, and biology, with the aim of -

  • substantially improving performance of current disease diagnosis and management strategies by developing simple, sensitive and low cost molecular diagnostics methods/devices
  • generating breakthroughs in fundamental sciences
Research Overview
Nanomachineries for Exosomes and Exosomal Biomarkers Analysis

The Shiddiky Laboratory is pursuing studies of the development of multifunctional magnetic nanomaterials based novel nanomachineries for the highly selective isolation and sensitive detection of exosome and exosomal biomarkers in patients with cancer and other diseases.

Read More About Nanomachineries

Nanomachineries for Exosomes and Exosomal Biomarkers Analysis
Novel Methods and Devices for Early Detection of Cancer and Other Diseases

The Shiddiky Laboratory is working on the development of novel technologies and POC diagnostic methods to detect diseases at the time and place of patient care using minimal specialised infrastructure.

Read More About POC Diagnostics

Novel Methods and Devices for Early Detection of Cancer and Other Diseases
‘Metal-Biomolecules’ Affinity Interaction for Genetic, Epigenetic, and Proteomic Biomarkers

A novel platform method based on metal-biomolecules affinity interaction (i.e., adsorption) for the analysis of a range of genetic, epigenetic, and proteomic biomarkers in patients with cancers and other diseases. This method can overcome the major technological drawbacks in current biosensing approaches.

Read More About Nanobiosensing

‘Metal-Biomolecules’ Affinity Interaction for Genetic, Epigenetic, and Proteomic Biomarkers
‘On-Farm’ Devices and Technologies for Broad-Scale Disease Surveillance of Crop Plants

The Shiddiky Laboratory focuses to develop portable devices and technologies for ‘on-farm’ analysis of pathogen species and pathogenic biomarkers in unprocessed plant extracts. Such a device would allow more rapid and cost-effective detection, control and management of the plant diseases.

Read More About On-Farm Devices

‘On-Farm’ Devices and Technologies for Broad-Scale Disease Surveillance of Crop Plants